This was the stock's second consecutive day of losses.

The new tariffs announced by President Donald Trump Wednesday afternoon are weighing on some top names in the medtech ...

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.

Boston Scientific plans to break ground soon on a major expansion in Maple Grove, a project that’s up for $1.66 million in ...

Looking into the current session, Boston Scientific Inc. BSX shares are trading at $96.89, after a 3.16% drop. Over the past month, the stock fell by 1.95%, but over the past year ...

Boston Scientific (NYSE: BSX) announced on social media that it completed its previously announced acquisition of Bolt ...

Boston Scientific received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA's 510(k) ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging ...

MARLBOROUGH, Mass., April 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first ...

The stock's fall snapped a two-day winning streak.